| |
Oral/injectable contraceptiveb
| | |
Condomb
| | |
ECsb
| | |
|---|
|
male
|
female
|
χ2
|
Pra
|
male
|
female
|
χ2
|
Pra
|
male
|
female
|
χ2
|
Pra
|
|---|
|
n = 101
|
n = 55
| | |
n = 1122
|
n = 956
| | |
n = 141
|
n = 70
| | |
|---|
|
Sexual partner’s request
|
49
|
33
|
3.62
|
0.06
|
26
|
15
|
38.59
|
< 0.01
|
26
|
24
|
0.07
|
0.79
|
|
Accessibility
|
22
|
24
|
0.07
|
0.79
|
23
|
19
|
5.01
|
0.03
|
23
|
16
|
0.95
|
0.33
|
|
Affordability
|
21
|
20
|
0.01
|
0.91
|
12
|
8
|
9.43
|
< 0.01
|
15
|
7
|
2.02
|
0.16
|
|
Practicality
|
36
|
49
|
2.67
|
0.10
|
58
|
59
|
0.09
|
0.76
|
51
|
69
|
3.94
|
0.05
|
|
Efficacy
|
47
|
44
|
0.12
|
0.73
|
65
|
64
|
0.39
|
0.53
|
58
|
54
|
0.22
|
0.64
|
|
Few side effects
|
27
|
36
|
1.57
|
0.21
|
64
|
70
|
8.33
|
< 0.01
|
53
|
56
|
0.10
|
0.75
|
|
Little influence on sexual sensation during intercourse
|
15
|
20
|
0.68
|
0.41
|
13
|
10
|
3.48
|
0.06
|
17
|
26
|
1.34
|
0.25
|
|
Others
|
1
|
4
|
1.32
|
0.25
|
1
|
1
|
0.65
|
0.42
|
2
|
4
|
0.55
|
0.46
|
- aPr for chi-square test
- bStudents who reported specific contraceptive use during last sexual intercourse were asked to provide reasons for contraception
